Thorsten Leucker, MD
Enriched profileAssociate Professor of Medicine; Director, Johns Hopkins Cardiovascular Clinical Research Unit (JH-CCRU); Director, Cardiology (Cardiovascular Disease) Fellowship Program; Director of Basic and Translational Vascular Biology Research, Ciccarone Center for the Prevention of Cardiovascular Disease · Johns Hopkins University School of Medicine
Thorsten Leucker is Associate Professor of Medicine; Director, Johns Hopkins Cardiovascular Clinical Research Unit (JH-CCRU); Director, Cardiology (Cardiovascular Disease) Fellowship Program; Director of Basic and Translational Vascular Biology Research, Ciccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins University School of Medicine. OpenAlex indexes 129 publications with 2,670 citations (h-index 28); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Thorsten Leucker, M.D., is Associate Professor of Medicine at Johns Hopkins University School of Medicine, Division of Cardiology, Baltimore, MD. The public record shows 129 publications with 2,670 citations (h-index 28), centered on Lipoproteins and Cardiovascular Health, Atherosclerosis and Cardiovascular Diseases, Cardiac Imaging and Diagnostics. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (2024–2025).
- Most recent indexed publication: 2026 · American journal of physiology. Heart and circulatory physiology
- Top research focus: Lipoproteins and Cardiovascular Health
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 40.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Pelacarsen Roll-over Extension Program
Sponsor: Novartis Pharmaceuticals
- Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
Sponsor: Johns Hopkins University
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Amgen Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
96.8%PCSK9 Inhibitor63%Repatha Sureclick78%Praluent Pen23%Part D≥43 patientsCholesterol absorption inhibitor15.9%Ezetimibe100%Part D≥18 patientsMetabolism & gastrointestinal
3.2%GLP-1 receptor agonist3.2%Ozempic100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
Johns Hopkins University
FY2025$713,464R01HL176322 - Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
Johns Hopkins University
FY2024$742,803R01HL176322 - ADDRESSING THE CONTINUING CHALLENGE OF IDENTIFYING AND MANAGING CORONARY RISK: A PERSON-SPECIFIC STRATEGY USING PROTEOMICS
Proteas Bioanalytics Inc.
FY2022$295,195R43HL166091
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Metabolic and redox pathway dysregulation in HIV-associated coronary endothelial dysfunction.
American journal of physiology. Heart and circulatory physiology
Article2026 - Lipoprotein(a) and oxidized phospholipids are associated with myocardial inflammation after acute myocardial infarction.
Nature cardiovascular research
Clinical Trial2026 - Lipoprotein(a) is associated with coronary inflammation in people with HIV and undetectable HIV RNA.
European heart journal. Imaging methods and practice
Article2026 - Lipoprotein(a) in clinical practice: Risk stratification and therapeutic strategies.
European journal of clinical investigation
Review2026
Most-cited works
by citation count (OpenAlex)- 01Inflammation and cardiovascular disease: From mechanisms to therapeuticsArticle459 citations2020
- 02
- 03Coronary heart disease risk: Low-density lipoprotein and beyondArticle236 citations2021
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/thorsten-leucker-a0823b178
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Thorsten-Leucker
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/TLeucker
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Other
medicine-matters.blogs.hopkinsmedicine.org/2022/10/leucker-named-director-of-cardiovascular-diseases-fellowship-program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗ - Other
medicine-matters.blogs.hopkinsmedicine.org/2025/04/leucker-post-and-segal-receive-dom-mentoring-awards
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.hopkinsmedicine.org ↗
- M.D.
University of Bonn Faculty of Medicine (Rheinische Friedrich-Wilhelms-Universität Bonn), 2008, summa cum laude
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Diplomate
American Board of Clinical Lipidology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.hopkinsmedicine.org ↗
Awards & honors
honors on the public record- Recipient
AHA Clinical Fellow Research Education Program funding for the Johns Hopkins Cardiology Fellowship Program
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine